[1] |
McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study [J].Am J Kidney Dis, 2003, 41(3): 571-579.
|
[2] |
Koch M, Trapp R, Kohnle M, et al. B-type natriuretic peptide and severe heart failure at baseline predict overall mortality in incident dialysis patients [J]. Clin Nephrol, 2010, 73(1): 21-29.
|
[3] |
Nakai S, Iseki K, Itami N, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2010) [J]. Ther Apher Dial 2012, 16(6): 483-521.
|
[4] |
Group KDIGOKCW. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease [J]. Kidney Int, 2013, 3(suppl): 1-150.
|
[5] |
Chazot C, Wabel P, Chamney P, et al. Importance of normohydration for the long-term survival of haemodialysis patients [J]. Nephrol Dial Transplant, 2012, 27(6): 2404-2410.
|
[6] |
David S, Kumpers P, Seidler V, et al. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis [J]. Nephrol Dial Transplant, 2008, 23(4): 1370-1377.
|
[7] |
Madsen LH, Ladefoged S, Corell P, et al. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis [J]. Kidney Int, 2007, 71(6): 548-554.
|
[8] |
Booth J, Pinney J, Davenport A. N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients[J] ? Clin J Am Soc Nephrol, 2010, 5(6): 1036-1040.
|
[9] |
Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death [J]. N Engl J Med, 2004, 350(7): 655-663.
|
[10] |
Roberts MA, Srivastava PM, Macmillan N, et al. B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis [J]. Clin J Am Soc Nephrol, 2008, 3(4): 1057-1065.
|
[11] |
Yasuda K, Kimura T, Sasaki K, et al. Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease [J]. Nephrol Dial Transplant, 2012, 27(10): 3885-3891.
|
[12] |
Yamada S, Ishii H, Takahashi H, et al. Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients [J]. Clin J Am Soc Nephrol, 2010, 5(10): 1793-1798.
|
[13] |
Kumar S, Khosravi M, Massart A, et al. Is there a role for N-terminalprobrain-type natriuretic peptide in determining volume status in haemodialysis patients [J] ? Nephron Clin Pract, 2012, 122(1-2): 33-37.
|
[14] |
Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients [J]. Am J Kidney Dis, 2007, 50(6): 1009-1019.
|
[15] |
Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis [J]. Kidney Int, 2007, 71(6): 548-554.
|